DCK anticorps

N° du produit ABIN7240775

Détail du produit anti-DCK anticorps

Antigène: DCK (Deoxycytidine Kinase (DCK))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp DCK est non-conjugé

Application: Western Blotting (WB), ELISA

Attributs du produit: Polyclonal Antibody

Purification: Affinity purification

Immunogène: Recombinant protein of human DCK

Isotype: IgG

Information d'application

Indications d'application: WB 1:200-1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.3 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur DCK

Antigène: DCK (Deoxycytidine Kinase (DCK))

Autre désignation: DCK (DCK Produits)

Synonymes: anticorps dck, anticorps DCK, anticorps wu:fc15f06, anticorps zgc:101771, anticorps dck1, anticorps deoxycytidine kinase, anticorps deoxycytidine kinase, gene 2 L homeolog, anticorps deoxycytidine kinase, gene 2, anticorps Deoxycytidine kinase, anticorps deoxycytidine kinase, gene 1 L homeolog, anticorps DCK, anticorps dck, anticorps dck.2.L, anticorps dck.2, anticorps Dck, anticorps FPV059, anticorps FPV151, anticorps dck.1.L

Sujet: Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity.

Poids moléculaire: 31 kDa

UniProt: P27707